Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis

Cyclin F, capable of forming Skp1‐Cul1‐F‐box protein ubiquitin ligase complex, is implicated in controlling centrosome duplication and preventing genome instability. Cyclin F oscillates during cell cycle with a similar pattern to cyclin A. However, its expression and significance in cancer remain ob...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer science 2013-04, Vol.104 (4), p.508-515
Hauptverfasser: Fu, Jia, Qiu, Huijuan, Cai, Muyan, Pan, Yinghua, Cao, Yun, Liu, Lili, Yun, Jingping, Zhang, Chris Zhiyi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 515
container_issue 4
container_start_page 508
container_title Cancer science
container_volume 104
creator Fu, Jia
Qiu, Huijuan
Cai, Muyan
Pan, Yinghua
Cao, Yun
Liu, Lili
Yun, Jingping
Zhang, Chris Zhiyi
description Cyclin F, capable of forming Skp1‐Cul1‐F‐box protein ubiquitin ligase complex, is implicated in controlling centrosome duplication and preventing genome instability. Cyclin F oscillates during cell cycle with a similar pattern to cyclin A. However, its expression and significance in cancer remain obscure. In this study, we showed that cyclin F was noticeably decreased in 16 pairs of tissue samples of hepatocellular carcinoma (HCC) compared to paracarcinoma tissues, at both mRNA and protein levels. Immunohistochemical staining data revealed that in 71.8% (176/245) of HCC cases, cyclin F expression in tumor tissue was much lower than that in nontumorous tissue. Low cyclin F expression, defined by receiver operating characteristic curve analysis, was present in 69.0% of HCC patients. Low expression of cyclin F was significantly correlated with tumor size, clinical stage, serum alpha‐fetoprotein level and tumor multiplicity. Further study showed that cyclin F expression was reversely associated with tumor differentiation in HCC. Kaplan–Meier analysis indicated that low cyclin F expression was related to poor overall survival and recurrence‐free survival. The prognostic impact of cyclin F was further confirmed by stratified survival analysis. Importantly, multivariate analysis revealed that low cyclin F expression was an independent poor prognostic marker for overall survival. We conclude that cyclin F is downregulated in HCC and is a promising prognostic marker for patients suffering from this deadly disease.
doi_str_mv 10.1111/cas.12100
format Article
fullrecord <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7657186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1319622809</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4720-b437af0c36e6f8545d42881535772c07e3a7c3a4981c19135b8758758bdfffc83</originalsourceid><addsrcrecordid>eNp1kctKxDAUhoMo3he-gGSpi2oubdNuBBm8wYALdR1O08SJdJKatI7z9mYcFV0YAkk4H9855EfoiJIzmta5gnhGGSVkA-1SnteZIKTc_LyLrCac7aC9GF8I4WVe59toh3FOCkbELgpTv8BqqTrr8DXW733QMVrvcHrPdA-DV7rrxg4CVhCUdX4OGGL0ysKgI17YYYZ77wNurTE6aDekwkoArsWjM_DmAzSdxn3wz85HGw_QloEu6sOvcx89XV89Tm6z6f3N3eRymqlcMJI1ORdgiOKlLk1V5EWbs6qiBS-EYIoIzUEoDnldUUVryoumEsVqN60xRlV8H12svf3YzHWr0mgBOtkHO4ewlB6s_Ftxdiaf_ZsUZSFoVSbByZcg-NdRx0HObVx9Bzjtxygpp3XJWEXqhJ6uURV8jEGbnzaUyFVGMmUkPzNK7PHvuX7I71AScL4GFrbTy_9NcnL5sFZ-ANXGnh4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1319622809</pqid></control><display><type>article</type><title>Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis</title><source>Wiley Open Access</source><creator>Fu, Jia ; Qiu, Huijuan ; Cai, Muyan ; Pan, Yinghua ; Cao, Yun ; Liu, Lili ; Yun, Jingping ; Zhang, Chris Zhiyi</creator><creatorcontrib>Fu, Jia ; Qiu, Huijuan ; Cai, Muyan ; Pan, Yinghua ; Cao, Yun ; Liu, Lili ; Yun, Jingping ; Zhang, Chris Zhiyi</creatorcontrib><description>Cyclin F, capable of forming Skp1‐Cul1‐F‐box protein ubiquitin ligase complex, is implicated in controlling centrosome duplication and preventing genome instability. Cyclin F oscillates during cell cycle with a similar pattern to cyclin A. However, its expression and significance in cancer remain obscure. In this study, we showed that cyclin F was noticeably decreased in 16 pairs of tissue samples of hepatocellular carcinoma (HCC) compared to paracarcinoma tissues, at both mRNA and protein levels. Immunohistochemical staining data revealed that in 71.8% (176/245) of HCC cases, cyclin F expression in tumor tissue was much lower than that in nontumorous tissue. Low cyclin F expression, defined by receiver operating characteristic curve analysis, was present in 69.0% of HCC patients. Low expression of cyclin F was significantly correlated with tumor size, clinical stage, serum alpha‐fetoprotein level and tumor multiplicity. Further study showed that cyclin F expression was reversely associated with tumor differentiation in HCC. Kaplan–Meier analysis indicated that low cyclin F expression was related to poor overall survival and recurrence‐free survival. The prognostic impact of cyclin F was further confirmed by stratified survival analysis. Importantly, multivariate analysis revealed that low cyclin F expression was an independent poor prognostic marker for overall survival. We conclude that cyclin F is downregulated in HCC and is a promising prognostic marker for patients suffering from this deadly disease.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.12100</identifier><identifier>PMID: 23305207</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Adolescent ; Adult ; Aged ; Biomarkers, Tumor - metabolism ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - pathology ; Cell Differentiation ; Cyclins - metabolism ; Down-Regulation ; Female ; Humans ; Liver Neoplasms - metabolism ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Male ; Middle Aged ; Original ; Prognosis ; Young Adult</subject><ispartof>Cancer science, 2013-04, Vol.104 (4), p.508-515</ispartof><rights>2013 Japanese Cancer Association</rights><rights>2013 Japanese Cancer Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4720-b437af0c36e6f8545d42881535772c07e3a7c3a4981c19135b8758758bdfffc83</citedby><cites>FETCH-LOGICAL-c4720-b437af0c36e6f8545d42881535772c07e3a7c3a4981c19135b8758758bdfffc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657186/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657186/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,11543,27903,27904,45553,45554,46030,46454,53769,53771</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.12100$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23305207$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fu, Jia</creatorcontrib><creatorcontrib>Qiu, Huijuan</creatorcontrib><creatorcontrib>Cai, Muyan</creatorcontrib><creatorcontrib>Pan, Yinghua</creatorcontrib><creatorcontrib>Cao, Yun</creatorcontrib><creatorcontrib>Liu, Lili</creatorcontrib><creatorcontrib>Yun, Jingping</creatorcontrib><creatorcontrib>Zhang, Chris Zhiyi</creatorcontrib><title>Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis</title><title>Cancer science</title><addtitle>Cancer Sci</addtitle><description>Cyclin F, capable of forming Skp1‐Cul1‐F‐box protein ubiquitin ligase complex, is implicated in controlling centrosome duplication and preventing genome instability. Cyclin F oscillates during cell cycle with a similar pattern to cyclin A. However, its expression and significance in cancer remain obscure. In this study, we showed that cyclin F was noticeably decreased in 16 pairs of tissue samples of hepatocellular carcinoma (HCC) compared to paracarcinoma tissues, at both mRNA and protein levels. Immunohistochemical staining data revealed that in 71.8% (176/245) of HCC cases, cyclin F expression in tumor tissue was much lower than that in nontumorous tissue. Low cyclin F expression, defined by receiver operating characteristic curve analysis, was present in 69.0% of HCC patients. Low expression of cyclin F was significantly correlated with tumor size, clinical stage, serum alpha‐fetoprotein level and tumor multiplicity. Further study showed that cyclin F expression was reversely associated with tumor differentiation in HCC. Kaplan–Meier analysis indicated that low cyclin F expression was related to poor overall survival and recurrence‐free survival. The prognostic impact of cyclin F was further confirmed by stratified survival analysis. Importantly, multivariate analysis revealed that low cyclin F expression was an independent poor prognostic marker for overall survival. We conclude that cyclin F is downregulated in HCC and is a promising prognostic marker for patients suffering from this deadly disease.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Differentiation</subject><subject>Cyclins - metabolism</subject><subject>Down-Regulation</subject><subject>Female</subject><subject>Humans</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Prognosis</subject><subject>Young Adult</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKxDAUhoMo3he-gGSpi2oubdNuBBm8wYALdR1O08SJdJKatI7z9mYcFV0YAkk4H9855EfoiJIzmta5gnhGGSVkA-1SnteZIKTc_LyLrCac7aC9GF8I4WVe59toh3FOCkbELgpTv8BqqTrr8DXW733QMVrvcHrPdA-DV7rrxg4CVhCUdX4OGGL0ysKgI17YYYZ77wNurTE6aDekwkoArsWjM_DmAzSdxn3wz85HGw_QloEu6sOvcx89XV89Tm6z6f3N3eRymqlcMJI1ORdgiOKlLk1V5EWbs6qiBS-EYIoIzUEoDnldUUVryoumEsVqN60xRlV8H12svf3YzHWr0mgBOtkHO4ewlB6s_Ftxdiaf_ZsUZSFoVSbByZcg-NdRx0HObVx9Bzjtxygpp3XJWEXqhJ6uURV8jEGbnzaUyFVGMmUkPzNK7PHvuX7I71AScL4GFrbTy_9NcnL5sFZ-ANXGnh4</recordid><startdate>201304</startdate><enddate>201304</enddate><creator>Fu, Jia</creator><creator>Qiu, Huijuan</creator><creator>Cai, Muyan</creator><creator>Pan, Yinghua</creator><creator>Cao, Yun</creator><creator>Liu, Lili</creator><creator>Yun, Jingping</creator><creator>Zhang, Chris Zhiyi</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201304</creationdate><title>Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis</title><author>Fu, Jia ; Qiu, Huijuan ; Cai, Muyan ; Pan, Yinghua ; Cao, Yun ; Liu, Lili ; Yun, Jingping ; Zhang, Chris Zhiyi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4720-b437af0c36e6f8545d42881535772c07e3a7c3a4981c19135b8758758bdfffc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Differentiation</topic><topic>Cyclins - metabolism</topic><topic>Down-Regulation</topic><topic>Female</topic><topic>Humans</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Prognosis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fu, Jia</creatorcontrib><creatorcontrib>Qiu, Huijuan</creatorcontrib><creatorcontrib>Cai, Muyan</creatorcontrib><creatorcontrib>Pan, Yinghua</creatorcontrib><creatorcontrib>Cao, Yun</creatorcontrib><creatorcontrib>Liu, Lili</creatorcontrib><creatorcontrib>Yun, Jingping</creatorcontrib><creatorcontrib>Zhang, Chris Zhiyi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Fu, Jia</au><au>Qiu, Huijuan</au><au>Cai, Muyan</au><au>Pan, Yinghua</au><au>Cao, Yun</au><au>Liu, Lili</au><au>Yun, Jingping</au><au>Zhang, Chris Zhiyi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis</atitle><jtitle>Cancer science</jtitle><addtitle>Cancer Sci</addtitle><date>2013-04</date><risdate>2013</risdate><volume>104</volume><issue>4</issue><spage>508</spage><epage>515</epage><pages>508-515</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>Cyclin F, capable of forming Skp1‐Cul1‐F‐box protein ubiquitin ligase complex, is implicated in controlling centrosome duplication and preventing genome instability. Cyclin F oscillates during cell cycle with a similar pattern to cyclin A. However, its expression and significance in cancer remain obscure. In this study, we showed that cyclin F was noticeably decreased in 16 pairs of tissue samples of hepatocellular carcinoma (HCC) compared to paracarcinoma tissues, at both mRNA and protein levels. Immunohistochemical staining data revealed that in 71.8% (176/245) of HCC cases, cyclin F expression in tumor tissue was much lower than that in nontumorous tissue. Low cyclin F expression, defined by receiver operating characteristic curve analysis, was present in 69.0% of HCC patients. Low expression of cyclin F was significantly correlated with tumor size, clinical stage, serum alpha‐fetoprotein level and tumor multiplicity. Further study showed that cyclin F expression was reversely associated with tumor differentiation in HCC. Kaplan–Meier analysis indicated that low cyclin F expression was related to poor overall survival and recurrence‐free survival. The prognostic impact of cyclin F was further confirmed by stratified survival analysis. Importantly, multivariate analysis revealed that low cyclin F expression was an independent poor prognostic marker for overall survival. We conclude that cyclin F is downregulated in HCC and is a promising prognostic marker for patients suffering from this deadly disease.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>23305207</pmid><doi>10.1111/cas.12100</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1347-9032
ispartof Cancer science, 2013-04, Vol.104 (4), p.508-515
issn 1347-9032
1349-7006
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7657186
source Wiley Open Access
subjects Adolescent
Adult
Aged
Biomarkers, Tumor - metabolism
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - pathology
Cell Differentiation
Cyclins - metabolism
Down-Regulation
Female
Humans
Liver Neoplasms - metabolism
Liver Neoplasms - mortality
Liver Neoplasms - pathology
Male
Middle Aged
Original
Prognosis
Young Adult
title Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A27%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20cyclin%20F%20expression%20in%20hepatocellular%20carcinoma%20associates%20with%20poor%20differentiation%20and%20unfavorable%20prognosis&rft.jtitle=Cancer%20science&rft.au=Fu,%20Jia&rft.date=2013-04&rft.volume=104&rft.issue=4&rft.spage=508&rft.epage=515&rft.pages=508-515&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.12100&rft_dat=%3Cproquest_24P%3E1319622809%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1319622809&rft_id=info:pmid/23305207&rfr_iscdi=true